Santiago, D.; Mangas-Sanjuan, V.; Melin, K.; Duconge, J.; Zhao, W.; Venkataramanan, R.
Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico. Pharmaceutics 2020, 12, 1226.
https://doi.org/10.3390/pharmaceutics12121226
AMA Style
Santiago D, Mangas-Sanjuan V, Melin K, Duconge J, Zhao W, Venkataramanan R.
Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico. Pharmaceutics. 2020; 12(12):1226.
https://doi.org/10.3390/pharmaceutics12121226
Chicago/Turabian Style
Santiago, Darlene, Victor Mangas-Sanjuan, Kyle Melin, Jorge Duconge, Wenchen Zhao, and Raman Venkataramanan.
2020. "Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico" Pharmaceutics 12, no. 12: 1226.
https://doi.org/10.3390/pharmaceutics12121226
APA Style
Santiago, D., Mangas-Sanjuan, V., Melin, K., Duconge, J., Zhao, W., & Venkataramanan, R.
(2020). Pharmacokinetic Characterization and External Evaluation of a Quantitative Framework of Sublingual Buprenorphine in Patients with an Opioid Disorder in Puerto Rico. Pharmaceutics, 12(12), 1226.
https://doi.org/10.3390/pharmaceutics12121226